NASDAQ · AEHA
Financial Services · Shell Companies
$9.96
Up+$0.22 (+2.27%)
Updated Sep 16, 2026, 9:17 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AEHA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning AEHA.
AEHA research
Company profile and research snapshot.
Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.
Consensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Feb 9, 2023
Multiple Patents granted for Methods and Composition for Mono-specific and Bi-specific antibody approaches that suppress tumors by targeting and neutralizing elevated levels of chitinase 3-like-1 (CHI3L1) and other mediators.
GlobeNewswire Inc. · Feb 6, 2023
NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company, today announced that its stockholders approved all proposals related to the previously announced proposed business combination between Aesther and Ocean at a special meeting of stockholders held on February 3, 2023. A Form 8-K disclosing the full voting results is expected to be filed with the Securities and Exchange Commission.
GlobeNewswire Inc. · Feb 1, 2023
NEW YORK and PROVIDENCE, R.I., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company announced today that AEHA has filed with the U.S. Securities and Exchange Commission ("SEC") a definitive proxy statement (“Definitive Proxy Statement") in connection with its proposed business combination (the “Business Combination” or the “Transaction”) with Ocean and with respect to the special meeting of Aesther’s stockholders (“Special Meeting”) scheduled to be held on February 3, 2023.
GlobeNewswire Inc. · Jan 24, 2023
Ocean Biomedical stock is expected to trade on the Nasdaq Capital Market under ticker symbol "OCEA"
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AEHA.
No results
No recent SID articles mention AEHA.
